<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Premsyn PMS</title><link>http://www.unboundmedicine.com/medline/ebm/research/Premsyn_PMS</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Herbs, Vitamins and Minerals in the Treatment of Premenstrual Syndrome: A Systematic Review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923637/full_citation/Herbs_Vitamins_and_Minerals_in_the_Treatment_of_Premenstrual_Syndrome:_A_Systematic_Review_</link><description>Whelan AM, Jurgens TM, Naylor H <br/><span class="title">Herbs, Vitamins and Minerals in the Treatment of Premenstrual Syndrome: A Systematic Review. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique">Can J Clin Pharmacol 2009; 16(3):e407-e429.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923637/abstract/Herbs_Vitamins_and_Minerals_in_the_Treatment_of_Premenstrual_Syndrome:_A_Systematic_Review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923637/full_citation/Herbs_Vitamins_and_Minerals_in_the_Treatment_of_Premenstrual_Syndrome:_A_Systematic_Review_">Full Citation</a></description></item><item><title>Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916992/full_citation/Influence_of_CYP2C19_polymorphism_on_the_pharmacokinetics_of_nelfinavir_and_its_active_metabolite_</link><description>Damle BD, Uderman H, Biswas P, et al. <br/><span class="title">Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2009 Nov; 68(5):682-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916992/abstract/Influence_of_CYP2C19_polymorphism_on_the_pharmacokinetics_of_nelfinavir_and_its_active_metabolite_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916992/full_citation/Influence_of_CYP2C19_polymorphism_on_the_pharmacokinetics_of_nelfinavir_and_its_active_metabolite_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0306-5251%26amp;date=2009%26amp;volume=68%26amp;issue=5%26amp;spage=682">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19916992/Influence_of_CYP2C19_polymorphism_on_the_pharmacokinetics_of_nelfinavir_and_its_active_metabolite_">Find Related Articles</a> </description></item><item><title>2-Amino-nonyl-6-methoxyl-tetralin muriate inhibits sterol C-14 reductase in the ergosterol biosynthetic pathway.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915585/full_citation/2_Amino_nonyl_6_methoxyl_tetralin_muriate_inhibits_sterol_C_14_reductase_in_the_ergosterol_biosynthetic_pathway_</link><description>Liang RM, Cao YB, Fan KH, et al. <br/><span class="title">2-Amino-nonyl-6-methoxyl-tetralin muriate inhibits sterol C-14 reductase in the ergosterol biosynthetic pathway. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta pharmacologica Sinica">Acta Pharmacol Sin 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915585/abstract/2_Amino_nonyl_6_methoxyl_tetralin_muriate_inhibits_sterol_C_14_reductase_in_the_ergosterol_biosynthetic_pathway_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915585/full_citation/2_Amino_nonyl_6_methoxyl_tetralin_muriate_inhibits_sterol_C_14_reductase_in_the_ergosterol_biosynthetic_pathway_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915585/2_Amino_nonyl_6_methoxyl_tetralin_muriate_inhibits_sterol_C_14_reductase_in_the_ergosterol_biosynthetic_pathway_">Find Related Articles</a> </description></item><item><title>Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19914920/full_citation/Short_term_implantation_related_complications_of_cardiac_rhythm_management_device_therapy:_a_retrospective_single_centre_1_year_survey_</link><description>Pakarinen S, Oikarinen L, Toivonen L <br/><span class="title">Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. [JOURNAL ARTICLE]</span><br/><span class="source" title="Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology">Europace 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19914920/abstract/Short_term_implantation_related_complications_of_cardiac_rhythm_management_device_therapy:_a_retrospective_single_centre_1_year_survey_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19914920/full_citation/Short_term_implantation_related_complications_of_cardiac_rhythm_management_device_therapy:_a_retrospective_single_centre_1_year_survey_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19914920/Short_term_implantation_related_complications_of_cardiac_rhythm_management_device_therapy:_a_retrospective_single_centre_1_year_survey_">Find Related Articles</a> </description></item><item><title>Curvature of Purple Membranes Comprising Permanently Wedge-Shaped Bacteriorhodopsin Molecules Is Regulated by Lipid Content.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19908872/full_citation/Curvature_of_Purple_Membranes_Comprising_Permanently_Wedge_Shaped_Bacteriorhodopsin_Molecules_Is_Regulated_by_Lipid_Content_</link><description>Rhinow D, Hampp N <br/><span class="title">Curvature of Purple Membranes Comprising Permanently Wedge-Shaped Bacteriorhodopsin Molecules Is Regulated by Lipid Content. [JOURNAL ARTICLE]</span><br/><span class="source" title="The journal of physical chemistry. B">J Phys Chem B 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19908872/abstract/Curvature_of_Purple_Membranes_Comprising_Permanently_Wedge_Shaped_Bacteriorhodopsin_Molecules_Is_Regulated_by_Lipid_Content_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19908872/full_citation/Curvature_of_Purple_Membranes_Comprising_Permanently_Wedge_Shaped_Bacteriorhodopsin_Molecules_Is_Regulated_by_Lipid_Content_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19908872/Curvature_of_Purple_Membranes_Comprising_Permanently_Wedge_Shaped_Bacteriorhodopsin_Molecules_Is_Regulated_by_Lipid_Content_">Find Related Articles</a> </description></item><item><title>Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19804692/full_citation/Sunitinib_for_the_treatment_of_gastrointestinal_stromal_tumours:_a_critique_of_the_submission_from_Pfizer_</link><description>Bond M, Hoyle M, Moxham T, et al. <br/><span class="title">Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Health technology assessment (Winchester, England)">Health Technol Assess 2009 Sep.:69-74.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19804692/abstract/Sunitinib_for_the_treatment_of_gastrointestinal_stromal_tumours:_a_critique_of_the_submission_from_Pfizer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19804692/full_citation/Sunitinib_for_the_treatment_of_gastrointestinal_stromal_tumours:_a_critique_of_the_submission_from_Pfizer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19804692/Sunitinib_for_the_treatment_of_gastrointestinal_stromal_tumours:_a_critique_of_the_submission_from_Pfizer_">Find Related Articles</a> </description></item><item><title>Double-Dosed Pantoprazole Accelerates the Sustained Symptomatic Response in Overweight and Obese Patients With Reflux Esophagitis in Los Angeles Grades A and B.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19904250/full_citation/Double_Dosed_Pantoprazole_Accelerates_the_Sustained_Symptomatic_Response_in_Overweight_and_Obese_Patients_With_Reflux_Esophagitis_in_Los_Angeles_Grades_A_and_B_</link><description>Chen WY, Chang WL, Tsai YC, et al. <br/><span class="title">Double-Dosed Pantoprazole Accelerates the Sustained Symptomatic Response in Overweight and Obese Patients With Reflux Esophagitis in Los Angeles Grades A and B. [JOURNAL ARTICLE]</span><br/><span class="source" title="The American journal of gastroenterology">Am J Gastroenterol 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19904250/abstract/Double_Dosed_Pantoprazole_Accelerates_the_Sustained_Symptomatic_Response_in_Overweight_and_Obese_Patients_With_Reflux_Esophagitis_in_Los_Angeles_Grades_A_and_B_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19904250/full_citation/Double_Dosed_Pantoprazole_Accelerates_the_Sustained_Symptomatic_Response_in_Overweight_and_Obese_Patients_With_Reflux_Esophagitis_in_Los_Angeles_Grades_A_and_B_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19904250/Double_Dosed_Pantoprazole_Accelerates_the_Sustained_Symptomatic_Response_in_Overweight_and_Obese_Patients_With_Reflux_Esophagitis_in_Los_Angeles_Grades_A_and_B_">Find Related Articles</a> </description></item><item><title>Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19903671/full_citation/Trend_of_the_main_clinical_characteristics_and_pacing_modality_in_patients_treated_by_pacemaker:_data_from_the_Italian_Pacemaker_Registry_for_the_quinquennium_2003_07_</link><description>Proclemer A, Ghidina M, Gregori D, et al. <br/><span class="title">Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07. [JOURNAL ARTICLE]</span><br/><span class="source" title="Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology">Europace 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19903671/abstract/Trend_of_the_main_clinical_characteristics_and_pacing_modality_in_patients_treated_by_pacemaker:_data_from_the_Italian_Pacemaker_Registry_for_the_quinquennium_2003_07_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19903671/full_citation/Trend_of_the_main_clinical_characteristics_and_pacing_modality_in_patients_treated_by_pacemaker:_data_from_the_Italian_Pacemaker_Registry_for_the_quinquennium_2003_07_">Full Citation</a></description></item><item><title>Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacological modification.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19903172/full_citation/Clinical_investigation_of_the_novel_iron_chelating_agent_CP94_to_enhance_topical_photodynamic_therapy_of_nodular_basal_cell_carcinoma:_further_explanation_of_a_dose_escalating_pilot_study_conducted_primarily_to_consider_the_safety_of_this_pharmacological_modification_</link><description>Curnow A, Campbell SM <br/><span class="title">Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacological modification. [JOURNAL ARTICLE]</span><br/><span class="source" title="The British journal of dermatology">Br J Dermatol 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19903172/full_citation/Clinical_investigation_of_the_novel_iron_chelating_agent_CP94_to_enhance_topical_photodynamic_therapy_of_nodular_basal_cell_carcinoma:_further_explanation_of_a_dose_escalating_pilot_study_conducted_primarily_to_consider_the_safety_of_this_pharmacological_modification_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19903172/Clinical_investigation_of_the_novel_iron_chelating_agent_CP94_to_enhance_topical_photodynamic_therapy_of_nodular_basal_cell_carcinoma:_further_explanation_of_a_dose_escalating_pilot_study_conducted_primarily_to_consider_the_safety_of_this_pharmacological_modification_">Find Related Articles</a> </description></item><item><title>Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19902987/full_citation/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_</link><description>Zhou SF <br/><span class="title">Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical pharmacokinetics">Clin Pharmacokinet 2009 Dec 1; 48(12):761-804.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19902987/abstract/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19902987/full_citation/Polymorphism_of_Human_Cytochrome_P450_2D6_and_Its_Clinical_Significance:_Part_II_">Full Citation</a></description></item></channel></rss>